The World Health Organization (WHO) has agreed on the recommended composition of the trivalent influenza vaccine for the northern hemisphere 2015-2016.
Bacteria in humans, food and animals continue to show resistance to the most widely used antimicrobials, says the latest report on antimicrobial resistance in zoonotic bacteria in Europe. Resistance to ciprofloxacin, an antimicrobial that is critically important for the treatment of human infections, continues to be very high in Campylobacter, thus reducing the options for effective treatment of severe foodborne infections. In addition, multi-drug resistant Salmonella bacteria continue to spread across Europe.
The peer-review visits identified some common good practices as well as a large degree of similarity in the challenges faced in preparing for possible Ebola cases.
The WHO recommendations reflect the currently circulating viruses in the southern hemisphere, and the change of both A(H3N2) and B virus components is based on the available surveillance and virus characterisation data.
The results from three animal species all point in the same direction: it seems possible to develop influenza vaccine candidates with at least broader cross-protection and possibly universal ones using different technologies.
Results from a recent vaccine trial, conducted by collaborating health authorities, possibly represent a major breakthrough in the control of Ebola virus disease.
This new publication from Novartis in collaboration with public health and academic researchers in Finland and the US adds to the evidence-base on how narcolepsy might have been triggered in genetically susceptible individuals.
On the occasion of the tenth anniversary of European Immunization Week, ECDC is releasing a new complement of data, tools, blogs and updates to support public health authorities in their work against vaccine preventable diseases.
The summary of the the first intercountry meeting, held in Copenhagen on 24-25 March 2015, hosted jointly by WHO/Europe and the European Centre for Disease Prevention and Control (ECDC) to address issues encountered by the national verfication committeees in European Union (EU)/European Economic Area (EEA) Member States.